<DOC>
	<DOC>NCT00482729</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy and safety of an investigational treatment for type 2 diabetes mellitus.</brief_summary>
	<brief_title>MK0431A Comparative Study in Patients With Type 2 Diabetes (0431A-079)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patient has type 2 diabetes mellitus Patient is greater than or equal to 18 and less than or equal to 78 years of age on the day of signing the consent Patient has Hb1Ac greater than or equal to 7.5% and is appropriate for oral therapy Patient has not been on any antihyperglycemic agent (AHA) in the last 4 months Patient is a male, or a female who is unlikely to conceive Patient has type 1 diabetes mellitus or history of ketoacidosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>